Geron
GERN
#5737
Rank
C$1.64 B
Marketcap
C$2.57
Share price
-2.08%
Change (1 day)
-31.03%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -C$64.95 Million

According to Geron's latest financial reports the company's current earnings are C$0.18 Billion. In 2024 the company made an earning of -C$0.22 Billion, an increase over its 2023 earnings that were of -C$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$64.95 Million-69.58%
2024 -C$0.22 Billion-11.23%
2023 -C$0.25 Billion30.22%
2022 -C$0.19 Billion20.15%
2021 -C$0.16 Billion50.08%
2020 -C$0.11 Billion4.46%
2019 -C$98.05 Million130.68%
2018 -C$42.51 Million8.84%
2017 -C$39.05 Million-3.08%
2016 -C$40.29 Million-22080.6%
2015 C$0.18 M-100.38%
2014 -C$48.68 Million-7.14%
2013 -C$52.42 Million
2011 -C$0.13 Billion19.04%
2010 -C$0.11 Billion8.45%
2009 -C$96.07 Million-2.51%
2008 -C$98.55 Million14.65%
2007 -C$85.96 Million32.68%
2006 -C$64.78 Million25.59%
2005 -C$51.58 Million4.36%
2004 -C$49.43 Million19.73%
2003 -C$41.29 Million-15.46%
2002 -C$48.84 Million1.94%
2001 -C$47.9 Million33.59%
2000 -C$35.86 Million27.53%
1999 -C$28.12 Million63.13%
1998 -C$17.24 Million15.6%
1997 -C$14.91 Million-10.66%
1996 -C$16.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.52 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$2.17 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$94.71 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.16 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$12.98 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA